Literature DB >> 24164375

Evaluation of a home-based colorectal cancer screening intervention in a rural state.

Mary E Charlton1, Michelle A Mengeling, Thorvardur R Halfdanarson, Nader M Makki, Ashish Malhotra, J Stacey Klutts, Barcey T Levy, Peter J Kaboli.   

Abstract

PURPOSE: Distance from health care facilities can be a barrier to colorectal cancer (CRC) screening, especially for colonoscopy. Alternatively, an improved at-home stool-based screening tool, the fecal immunochemical test (FIT), requires only a single sample and has a better sensitivity-specificity balance compared to traditional guaiac fecal occult blood tests. Our objective was to determine if FITs mailed to asymptomatic, average-risk patients overdue for screening resulted in higher screening rates versus mailing educational materials alone or no intervention (ie, usual care).
METHODS: Veterans ages 51-64, asymptomatic, at average risk for CRC, overdue for screening and in a veterans administration (VA) catchment area covering a large rural population were randomly assigned to 3 groups: (1) education only (Ed) group: mailed CRC educational materials and a survey of screening history and preferences (N = 499); (2) FIT group: mailed the FIT, plus educational materials and survey (N = 500); and (3) usual care (UC) group: received no mailings (N = 500).
FINDINGS: At 6 months postintervention, 21% of the FIT group had received CRC screening by any method compared to 6% of the Ed group (and 6% of the UC group) (P < .0001). Of the 105 respondents from the FIT group, 71 (68%) were eligible to take the FIT. Of those, 64 (90%) completed the FIT and 8 (12%) tested positive.
CONCLUSIONS: This low-intensity intervention of mailing FITs to average risk patients overdue for screening resulted in a significantly higher screening rate than educational materials alone or usual care, and may be of particular interest in rural areas.
© 2013 National Rural Health Association.

Entities:  

Keywords:  access to care; colorectal cancer screening; fecal immunochemical test; health services research; program evaluation

Mesh:

Year:  2013        PMID: 24164375      PMCID: PMC4266988          DOI: 10.1111/jrh.12052

Source DB:  PubMed          Journal:  J Rural Health        ISSN: 0890-765X            Impact factor:   4.333


  31 in total

Review 1.  Hereditary colorectal cancer.

Authors:  Henry T Lynch; Albert de la Chapelle
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

2.  Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.

Authors:  Alicia Smith; Graeme P Young; Stephen R Cole; Peter Bampton
Journal:  Cancer       Date:  2006-11-01       Impact factor: 6.860

3.  Patient preferences and adherence to colorectal cancer screening in an urban population.

Authors:  Randi L Wolf; Charles E Basch; Corey H Brouse; Celia Shmukler; Steven Shea
Journal:  Am J Public Health       Date:  2006-03-29       Impact factor: 9.308

4.  Colorectal cancer testing among patients cared for by Iowa family physicians.

Authors:  Barcey T Levy; Jeffrey Dawson; Arthur J Hartz; Paul A James
Journal:  Am J Prev Med       Date:  2006-07-21       Impact factor: 5.043

5.  The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.

Authors:  Hashem B El-Serag; Laura Petersen; Howard Hampel; Peter Richardson; Gregory Cooper
Journal:  Arch Intern Med       Date:  2006-11-13

6.  Barriers to cancer screening by rural Appalachian primary care providers.

Authors:  Renee Shell; Fred Tudiver
Journal:  J Rural Health       Date:  2004       Impact factor: 4.333

7.  Factors associated with colon cancer screening: the role of patient factors and physician counseling.

Authors:  Christina C Wee; Ellen P McCarthy; Russell S Phillips
Journal:  Prev Med       Date:  2004-12-29       Impact factor: 4.018

8.  Barriers to colorectal cancer screening among Medicare consumers.

Authors:  Carrie N Klabunde; Anna P Schenck; William W Davis
Journal:  Am J Prev Med       Date:  2006-04       Impact factor: 5.043

9.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

Authors:  S J Winawer; A G Zauber; M N Ho; M J O'Brien; L S Gottlieb; S S Sternberg; J D Waye; M Schapiro; J H Bond; J F Panish
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

10.  Screening rates and characteristics of health plan members who respond to screening reminders.

Authors:  Jun Zhu; James Davis; Deborah A Taira; Marisa Yamashita
Journal:  Prev Chronic Dis       Date:  2006-03-15       Impact factor: 2.830

View more
  16 in total

1.  Veterans' Continued Participation in an Annual Fecal Immunochemical Test Mailing Program for Colorectal Cancer Screening.

Authors:  Jennifer A Schlichting; Michelle A Mengeling; Nader M Makki; Ashish Malhotra; Thorvardur R Halfdanarson; J Stacey Klutts; Barcey T Levy; Peter J Kaboli; Mary E Charlton
Journal:  J Am Board Fam Med       Date:  2015 Jul-Aug       Impact factor: 2.657

2.  Two Medicaid health plans' models and motivations for improving colorectal cancer screening rates.

Authors:  Jennifer K Coury; Jennifer L Schneider; Beverly B Green; Laura-Mae Baldwin; Amanda F Petrik; Jennifer S Rivelli; Malaika R Schwartz; Gloria D Coronado
Journal:  Transl Behav Med       Date:  2020-02-03       Impact factor: 3.046

3.  Geographic and population-level disparities in colorectal cancer testing: A multilevel analysis of Medicaid and commercial claims data.

Authors:  Melinda M Davis; Stephanie Renfro; Robyn Pham; Kristen Hassmiller Lich; Jackilen Shannon; Gloria D Coronado; Stephanie B Wheeler
Journal:  Prev Med       Date:  2017-05-13       Impact factor: 4.018

4.  Who Performs Colonoscopy? Workforce Trends Over Space and Time.

Authors:  Jan M Eberth; Michele J Josey; Lee R Mobley; Davidson O Nicholas; Donna B Jeffe; Cassie Odahowski; Janice C Probst; Mario Schootman
Journal:  J Rural Health       Date:  2017-11-16       Impact factor: 4.333

5.  An RCT of Fecal Immunochemical Test Colorectal Cancer Screening in Veterans Without Recent Primary Care.

Authors:  Matthew A Goldshore; Shivan J Mehta; Woodrow Fletcher; George Tzanis; Chyke A Doubeni; E Carter Paulson
Journal:  Am J Prev Med       Date:  2020-07       Impact factor: 5.043

6.  A Randomized Controlled Trial of Opt-in Versus Opt-Out Colorectal Cancer Screening Outreach.

Authors:  Shivan J Mehta; Tanya Khan; Carmen Guerra; Catherine Reitz; Timothy McAuliffe; Kevin G Volpp; David A Asch; Chyke A Doubeni
Journal:  Am J Gastroenterol       Date:  2018-12       Impact factor: 10.864

7.  Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis.

Authors:  Michael K Dougherty; Alison T Brenner; Seth D Crockett; Shivani Gupta; Stephanie B Wheeler; Manny Coker-Schwimmer; Laura Cubillos; Teri Malo; Daniel S Reuland
Journal:  JAMA Intern Med       Date:  2018-12-01       Impact factor: 21.873

8.  Increasing colorectal cancer screening in an overdue population: participation and cost impacts of adding telephone calls to a FIT mailing program.

Authors:  Jennifer A Schlichting; Michelle A Mengeling; Nader M Makki; Ashish Malhotra; Thorvardur R Halfdanarson; J Stacey Klutts; Barcey T Levy; Peter J Kaboli; Mary E Charlton
Journal:  J Community Health       Date:  2014-04

9.  Comparative effectiveness of mailed reminders with and without fecal immunochemical tests for Medicaid beneficiaries at a large county health department: A randomized controlled trial.

Authors:  Alison T Brenner; Jewels Rhode; Jeff Y Yang; Dana Baker; Rebecca Drechsel; Marcus Plescia; Daniel S Reuland; Tom Wroth; Stephanie B Wheeler
Journal:  Cancer       Date:  2018-07-13       Impact factor: 6.860

10.  A community-based trial of educational interventions with fecal immunochemical tests for colorectal cancer screening uptake among blacks in community settings.

Authors:  Shannon M Christy; Stacy N Davis; Kimberly R Williams; Xiuhua Zhao; Swapomthi K Govindaraju; Gwendolyn P Quinn; Susan T Vadaparampil; Hui-Yi Lin; Steven K Sutton; Richard R Roethzeim; David Shibata; Cathy D Meade; Clement K Gwede
Journal:  Cancer       Date:  2016-07-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.